The prestigious Hotel Marriott Marquis in New York hosted the important Podiatric Clinical Conference and Exhibition 2016 from 22nd to 24th January. The event, which was aimed at podiatrists and specialists interested in knowing about product, technological and therapy novelties, is a showcase of excellence with workshops and scientific conferences, and ASAlaser certainly couldn’t miss it. In spite of the unfavourable weather, the event dedicated to details and exchanges of experience in the podiatric environment drew a large number of visitors even this year. The stand of our local distributor, Cutting Edge Laser Technologies, was in a favourable position at the front, and it stood out because it was the only company present with a class IV Laser device. During the event, our partner’s staff showcased MLS® Laser Therapy, giving particular attention to M6, the robotised laser system that is obtaining excellent results even overseas.
“During the event I was pleased to meet some important clients,” said Lucio Zaghetto, CEO of ASAlaser, “who were delighted to be using such an important therapy for the wellbeing of their patients. They assured me that they had an extremely high success rate (almost 90%) with MLS®, even when used to treat the most acute pathologies”.
“Once again the doctors who took part in the Conference appreciated our presence.” said Byron E. Uppercue, Medical Division Sales Manager of Cutting Edge Laser Technologies. “The turnout would have been even higher if the weather had been better. NYSPMA is one of the main training events for doctors in the state of New York, and is greatly respected and well attended, year after year”.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.